ES2054668T3 - Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica. - Google Patents

Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica.

Info

Publication number
ES2054668T3
ES2054668T3 ES87304427T ES87304427T ES2054668T3 ES 2054668 T3 ES2054668 T3 ES 2054668T3 ES 87304427 T ES87304427 T ES 87304427T ES 87304427 T ES87304427 T ES 87304427T ES 2054668 T3 ES2054668 T3 ES 2054668T3
Authority
ES
Spain
Prior art keywords
pharmaceutical composition
carcinomas
diseases
treatment
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87304427T
Other languages
English (en)
Inventor
Juan Carlos Vidal
Luis Alberto Costa
Plata Guillermo Jose Hernandez
Molina Carlos Maria Coni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ventech Research Inc
Original Assignee
Ventech Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ventech Research Inc filed Critical Ventech Research Inc
Application granted granted Critical
Publication of ES2054668T3 publication Critical patent/ES2054668T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)

Abstract

COMPLEJO DE CROTOXINA SUBGRUPOS A Y B OBTENIBLE MEDIANTE SEPARACION CROMATOGRAFICA A PARTIR DE VENENO EN BRUTO DE CROTALUS DURSSUS TERRIFICUS, ES UTIL PARA EL TRATAMIENTO DE CARCINOMAS Y TRASTORNOS VASCULARES, INFECCIOSOS O ENDOCRINOS, TALES COMO DIABETES, Y PARA EL TRATAMIENTO DEL DOLOR EN GENERAL.
ES87304427T 1986-05-19 1987-05-19 Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica. Expired - Lifetime ES2054668T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AR30400686 1986-05-19
AR30419586 1986-06-02

Publications (1)

Publication Number Publication Date
ES2054668T3 true ES2054668T3 (es) 1994-08-16

Family

ID=25590979

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87304427T Expired - Lifetime ES2054668T3 (es) 1986-05-19 1987-05-19 Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica.

Country Status (4)

Country Link
EP (1) EP0246861B1 (es)
JP (1) JPH0720875B2 (es)
DE (1) DE3784768T2 (es)
ES (1) ES2054668T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE435023T1 (de) * 1996-09-11 2009-07-15 Elizabeth Shanahan-Prendergast Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen
SG129211A1 (en) * 1997-11-06 2007-02-26 Univ Singapore Therapeutic molecules
US7208150B1 (en) 1999-07-14 2007-04-24 S.I.S. Shulov Institute For Science Ltd. Analgesic from snake venom
EP1391207A1 (en) * 2001-04-24 2004-02-25 Luis Alberto Costa Use of a phospholipase a2 for the preparation of pharmaceutical and/or cosmetic compositions for the local and/or systematic treatment and/or prevention of diseases and/or processes caused by intra- and extracellular pathogens expressing membrane phospholipids
DE10322656A1 (de) * 2003-05-20 2004-12-09 Toximed Gmbh Pharmazeutischer Wirkstoff
AU2005239771B2 (en) * 2004-05-06 2011-03-10 Yara Cury Analgesic peptides derived from the venom of crotalus durissus terrificuss snakes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE675605C (de) * 1936-09-11 1939-06-02 August Wolff Sudbracker Naehrm Verfahren zur Trennung und Gewinnung der wertvollen Bestandteile des Bienen- und Schlangengiftes
US4341762A (en) * 1981-04-07 1982-07-27 Haast William E Use of snake venoms for treatment of neurological and related disorders

Also Published As

Publication number Publication date
DE3784768D1 (de) 1993-04-22
JPH0720875B2 (ja) 1995-03-08
EP0246861A3 (en) 1989-01-04
DE3784768T2 (de) 1993-06-24
JPS6333334A (ja) 1988-02-13
EP0246861A2 (en) 1987-11-25
EP0246861B1 (en) 1993-03-17

Similar Documents

Publication Publication Date Title
Fernando et al. Effect of Artocarpus heterophyllus and Asteracanthus longifolia on glucose tolerance in normal human subjects and in maturity-onset diabetic patients
NO146456C (no) Fremgangsmaate for fremstilling av kapsellegeme, saerlig for medisindoseringskapsel
ES2026708T3 (es) Jeringa de dos camaras con una carga de proteina humana sensible a la actividad como principio activo.
DK0641561T3 (da) Medicinsk anordning til indgivelse af aktive bestanddele eller medikamenter i meget lave doser, specielt homøopatiske medik
DE112013001457T5 (de) Transdermales Applikationssystem
ES2196849T3 (es) 4-amino-2-aril-pirimidinas sustituidas, su preparacion, su utilizacion y preparados farmaceuticos que las contienen.
ES2054668T3 (es) Composicion farmaceutica util para el tratamiento de carcinomas y otras enfermedades y un proceso para la preparacion del componente activo y de la composicion farmaceutica.
YU46705B (sh) Postupak za proizvodnju matrice za ispuštanje i/ili doziranje doziranje lekovite aktivne materije
ATE205401T1 (de) Lokale behandlung von psoriasis unter verwendung neutralisierender antikörper gegen il-8
Fritz et al. Plasma levels and efficacy of imipramine treatment for enuresis
Alvarez-Mena et al. Phenothiazine-induced T-wave abnormalities: effects of overnight fasting
CY1108648T1 (el) Αναστολεας της αρωματασης σε μια δοση για την θεραπευτικη αντιμετωπιση της υπογόνιμοτήτας
NO873273D0 (no) Flergranultablett for avgivelse av en aktiv bestanddel over tid.
EP1050309A4 (en) NEUROTROPHIC FACTOR SECRETION PROMOTERS
Jhaveri et al. Relationship of blood pressure to blood lead concentrations in small children
Versteeg et al. Inhibition of centrally-evoked pressor responses by neurohypophyseal peptides and their fragments
EA200200801A1 (ru) Применение фолликулостимулирующего гормона (fsh) для лечения бесплодия
AR042308A1 (es) Medicamento de administracion transdermica y transmucosica con absorcion mejorada de principios activos
Burch et al. Time course of plasma drug levels during once-daily oral administration of clomipramine
Perlman A study of the therapeutic action and toxicity of pentaerythritol tetranitrate
Bombardt et al. A GC/CIMS assay for the cis and trans isomers of thiothixene in human plasma.
NO165917C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt diamino-2,2-difluorhex-5-yn.
Breckenridge Oral anticoagulants--the totem and the taboo.
SU569310A1 (ru) Вещество,про вл ющее туберкулостатическую активность
Innerfield et al. Plasma antithrombin elevations in buccal varidasetreated patients

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 246861

Country of ref document: ES